Shenghua Biok generates the capacity of manufactruing synthetic drugs, injections, tablets and premixes. Information and technology are its top concern. Multi-year research agreement and long-term collaboration with top universities and institutes is aiming to strengthen its competitiveness. Team-building programmes and recruitment strategies are the key to business success. The comapny is exepcted to take the lead in this field with biological pesticides dominating the sales. The total sales of 2000 accounted for 204.5789million with the net profits of 72.0855 million and taxes paid of 12.2038 million.

Formed in 1993, Zhejiang Shenghua Biok Biology Co., Ltd., is currently a stock-moneyed company having a staff of 1100 out of whom 350 are technicians and 12 senior engineers. It is organised into two sectors: biochemicals and synthetic materials, including Avermectin, Ivermectn, Maduramicin, Diclazuril, Salinomycin and synthetically made herbicides and their intermediates. The companys strategy is to grow its business by seeking sustainable development through science and technological rennovation and survival by quality improvement.